REQUEST A DEMO
Total
USD $0.00
Search more companies

Fresenius Kabi Oncology Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing | Research and Development in the Physical, Engineering, and Life Sciences
Full name: Fresenius Kabi Oncology Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Fresenius Kabi Oncology Limited is based in India, with the head office in New Delhi. The company operates in the Pharmaceutical and Medicine Manufacturing industry. It was established on March 18, 2003. The total number of employees is currently 1,167 (2024). From the latest financial highlights, Fresenius Kabi Oncology Limited reported a net sales revenue increase of 9.66% in 2024. There was a total growth of 2.38% in Fresenius Kabi Oncology Limited’s total assets over the same period. In 2024, Fresenius Kabi Oncology Limited’s net profit margin increased by 0.57%.

Legal Address
B- 310, Som Datt Chambers - I Bhikaji Cama Place
New Delhi; Delhi; Postal Code: 110066

Contact Details: Purchase the Fresenius Kabi Oncology Limited report to view the information.

Website: http://www.fresenius-kabi- oncology.com

Basic Information
Total Employees:
Purchase the Fresenius Kabi Oncology Limited report to view the information.
Outstanding Shares:
Purchase the Fresenius Kabi Oncology Limited report to view the information.
Registered Capital:
Purchase the Fresenius Kabi Oncology Limited report to view the information.
Financial Auditors:
Purchase the Fresenius Kabi Oncology Limited report to view the information.
Incorporation Date:
March 18, 2003
Key Executives
Purchase this report to view the information.
Additional Executive Director
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
Whole Time Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Dabur Pharma ( Thailand ) Co.Ltd.
Fresenius Kabi Oncology Inc USA
Fresenius Kabi Oncology Plc.UK
Company Performance
Financial values in the chart are available after Fresenius Kabi Oncology Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
9.66%
Total Operating Revenue
7.77%
Operating Profit
23.19%
EBITDA
16.64%
Net Profit/Loss for the Period
19.67%
Total Assets
2.38%
Total Equity
4.34%
Operating Profit Margin
1.1%
Net Profit Margin
0.57%
Return on Equity (ROE)
0.52%
Debt / Equity
-0.05%
Quick Ratio
-0.21%
Cash Ratio
0.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?